Quarterly report pursuant to Section 13 or 15(d)

Schedule of receivables with imputed interest (Details)

v3.24.3
Schedule of receivables with imputed interest (Details) - USD ($)
Sep. 30, 2024
Jun. 11, 2024
Dec. 31, 2023
Receivables [Abstract]      
Face value $ 287,200 [1] $ 287,200 $ 285,400 [1]
Impairment (250,208) 250,208
Total 36,992   285,400
Unamortized discount (36,992) $ (36,992) (46,551)
Net balance   238,849
Current portion  
Long term portion   $ 238,849
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 was reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments at the nine months ended September 30, 2024.